FAQs ABOUT REJUNURON DN TABLET
Q: Can REJUNURON DN TABLET affect fertility?
A: Fertility studies in men have shown that there were no effects on sperm motility. However, REJUNURON DN TABLET can be associated with an increased risk of male-mediated teratogenicity (abnormalities in fetus). Men being treated with REJUNURON DN TABLET who plan to father a child should be informed about the potential risk of male-mediated teratogenicity. There are not enough clinical data on the effects of this medicine on female fertility.
Q: Can REJUNURON DN TABLET cause weight gain?
A: Yes, REJUNURON DN TABLET can cause weight gain in some individuals mainly due to the formation of peripheral edema (fluid retention). Weight gain can be more prominent among diabetic patients who are treated with thiazolidinediones (Ex. pioglitazone, rosiglitazone) and so inform your doctor if you have diabetes prior to treatment with REJUNURON DN TABLET as a precaution.
Q: Can REJUNURON DN TABLET decrease libido?
A: Yes, REJUNURON DN TABLET may cause decrease in sex drive (libido) in some individuals, although not everybody gets them. Consult your doctor if this symptom troubles you.
Q: Is REJUNURON DN TABLET addictive?
A: Yes, REJUNURON DN TABLET has high potential to create substance abuse or dependence and therefore caution should be exercised among patients who already has a history of substance abuse. Careful monitoring of symptoms of abuse are required in such patients.
Q: Can I stop taking REJUNURON DN TABLET once my pain is relieved?
A: No. Do not stop taking REJUNURON DN TABLET without consulting your doctor as it could precipitate withdrawal symptoms such as headache, lack of sleep, nausea, pain, diarrhea, flu syndrome, anxiety, nervousness, depression, convulsion, hyperhidrosis and dizziness and dependence. If your condition improves, contact your doctor so that he might reduce the dose appropriately before discontinuation of the therapy with REJUNURON DN TABLET.